International Clinical and Medical Case Reports Journal (ISSN: 2832-5788) | Volume 1, Issue 4 | Case Report | Open Access
Syed Madeeha Sadiq DO*
Internal Medicine, East Tennessee State University Quillen College of Medicine, Johnson City, USA
*Correspondence to: Syed Madeeha Sadiq DOFulltext PDF
Introduction: Immune Thrombocytopenia (ITP) is an autoimmune hematologic disorder characterized bydestruction of platelets and decreased platelet production due to antibodies directed againstplatelet surface glycoproteins.ITP can be both primary with unknown etiology and secondary,presenting after viral illness, with concurrent autoimmune disease, or post vaccination. Severesecondary immune thrombocytopenia has been recorded after administration of both Pfizer and Moderna SARS-CoV-2 vaccination. Our goal is to alert clinicians to the relationship of de novopost-vaccination ITP after administration of the SARS-CoV-2 vaccines, specifically inimmunosuppressedpopulations.
SARS-CoV-2; Vaccine; Immune Thrombocytopenia (ITP)
Syed Madeeha Sadiq DO, Katherine L Keith MS3, Miranda, Alexis Carmen MS3, Arthur Cecchini DO, Raza Hussain MD, Deidre Pierce MD.An Unusual Case of Severe Vaccine Induced Immunologic Thrombocytopenia Purpura from Moderna SARS-CoV-2 Vaccination in an Immunocompromised Patient.Int Clinc Med Case Rep Jour. 2022;1(3):1-3.